Hemera Biosciences LLC
Verified IntelHemera is a clinical stage gene therapy company that was founded with the sole mission of preserving vision using gene therapy as a one-time treatment in our patients with age-related macular degeneration (AMD). As physicians and scientists, we have been frustrated by our inability to provide treatment for our patients with macular degeneration. We embarked on this mission to preserve vision by developing a gene therapy called HMR59. Currently, HMR59 is under FDA clinical trial testing as a one-time treatment for both the dry and wet forms of AMD. HMR59 is injected during a routine office visit with the goal of preserving vision that will endure the life of our patients.
Hemera is a clinical stage gene therapy company that was founded with the sole mission of preserving vision using gene therapy as a one-time treatment in our patients with age-related macular degeneration (AMD). As physicians and scientists, we have been frustrated by our inability to provide treatment for our patients with macular degeneration. We embarked on this mission to preserve vision by developing a gene therapy called HMR59. Currently, HMR59 is under FDA clinical trial testing as a one-time treatment for both the dry and wet forms of AMD. HMR59 is injected during a routine office visit with the goal of preserving vision that will endure the life of our patients.
Corporate Firmographics
Entity classification and operating profile
- Industry
- General
- Company Type
- Privately Held
- Founded
- 2010
- Employee Bracket
- Myself Only
- Estimated Revenue Range
- Undisclosed
Geographic Coordinates
Headquarters address and regional territory
- Street Address
- 800 South St Massachusetts Waltham
- City
- Boston
- Region / State
- Massachusetts
- Postal Code
- 02453
- Country
- United States
Digital Presence & Footprint
Verified domains, socials, and directory profiles
Frequently Asked Questions
Verified business inquiries and firmographic telemetry for Hemera Biosciences LLC.